Coronavirus / COVID

While patients who developed a severe case of COVID-19 were at the highest risk, it was not limited to them.

Face masks protect from COVID-19, but multilayered ones made of certain materials perform better than others.

While the therapy did not meet its primary endpoint, it did show a statistically significant reduction in mortality compared to stand of care alone.

The United Kingdom’s Medicines and Healthcare products Regulatory Agency is making this recommendation for people in this age group after rare blot clots occurred after administration of the AstraZeneca vaccine.

The United States has experienced 23% more deaths than anticipated during the first year of the pandemic, according to a new analysis.

While symptom checkers have the potential to significantly help with overburdened systems, not enough people know about them.

The preclinical study showed that intranasal administration of OMV-Spike protected against the SARS-CoV-2 virus.

Current evidence remains uncertain to predict natural immunity conferred by SARS-CoV-2 infection, according to living practice points developed by the American College of Physicians (ACP), which urges patients to continue infection prevention practices such as hand washing, mask wearing and maintaining physical distance.

While it was a small study, its findings indicate protection against COVID-19 variants from the vaccine and from recovery from the infection.

The therapy used plasma from recoverees with high levels of antibodies and proved to significantly improve clinical outcomes.

mRNA-1273 was seen to elicit antibodies for COVID-19 180 days following full dosage in a phase 1 trial and is still recommended for use by the authors.

The study suggests that proper air ventilation and masks could reduce the risk of infections in classrooms by up to 50%, making a 6-foot social distancing requirement unnecessary.

Laboratory escape is described as an extremely unlikely source for SARS-CoV-2 in new WHO report, but questions posed to the researchers remain open.

As we hopefully inch closer to a point where COVID-19 numbers are declining and vaccinations are increasing, there is more attention to what risk factors might impact infections, hospitalizations, and mortality.

The crossover will allow all trial participants to receive the vaccine while remaining blinded.

Biopharmaceutical company, NeuroRx, reported positive data from its phase 2/3 trial for its therapy, aviptadil acetate (Zyesami), in patients with severe COVID-19.

India recorded over 100,000 cases on Sunday, the countries highest daily total ever.

An expert stresses the need to consider individuals' worry over information—and even their history with systemic biases.

Vaccine access and new cases are both increasing. An expert discusses earning trust in at-risk communities.

The screening methods used in the study proved to be reliable and inexpensive alternatives to the current standard used in testing.

Health regulators in the UK have now found 30 cases involving rare blood clot events after the administration of the AstraZeneca COVID-19 vaccine, but still recommend its use.

Hospitalized patients with COVID-19 and chronic inflammatory diseases were seen to have no statistically significant increased length of hospital stay or need for mechanical ventilation.

The federal agency said people who are fully vaccinated “are less likely to get and spread COVID-19,” and can travel safely in the United States.

The 2 revisions made to the EUA pertain to the number of doses allotted to the current vials containing the vaccine, and allow a new vial that has a maximum of 15 doses.

Investigators discovered that the variant was in many other countries before it was discovered and created a tool to help detect emerging variants in the future.